Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development.
暂无分享,去创建一个
J. Fata | R. Khokha | J E Fata | K J Leco | R A Moorehead | D C Martin | R Khokha | R. Moorehead | K. Leco | D. Martin | D. C. Martin
[1] L. Matrisian,et al. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. , 1996, The international journal of biochemistry & cell biology.
[2] Z. Werb,et al. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene , 1996, The Journal of cell biology.
[3] P. Waterhouse,et al. A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. , 1986, Nucleic acids research.
[4] G. Church,et al. Genomic sequencing. , 1993, Methods in molecular biology.
[5] P. Rudland,et al. Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[6] W. Stetler-Stevenson,et al. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. , 1996, Seminars in cancer biology.
[7] R. Heller,et al. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. , 1997, Critical reviews in eukaryotic gene expression.
[8] C. Daniel,et al. Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. , 1982, Developmental biology.
[9] R. Timpl,et al. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. , 1997, European journal of biochemistry.
[10] A. Eisen,et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Khokha. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. , 1994, Journal of the National Cancer Institute.
[12] E. Hay. Extracellular matrix alters epithelial differentiation. , 1993, Current opinion in cell biology.
[13] Z. Werb,et al. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution , 1992, The Journal of cell biology.
[14] M. Bissell,et al. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Taylor,et al. The Mechanism of Inhibition of Collagenase by TIMP-1* , 1996, The Journal of Biological Chemistry.
[16] D. Miles,et al. Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.
[17] E. Boylan,et al. Mammary gland morphology and responsiveness to regulatory molecules following prenatal exposure to diethylstilbestrol. , 1993, Teratogenesis, carcinogenesis, and mutagenesis.
[18] D. Stern,et al. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[19] C. Q. Lin,et al. Extracellular matrix regulates whey acidic protein gene expression by suppression of TGF-alpha in mouse mammary epithelial cells: studies in culture and in transgenic mice , 1995, The Journal of cell biology.
[20] K. Iwata,et al. Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.
[21] K. Suzuki,et al. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. , 1994, Endocrinology.
[22] J. Kere,et al. Human TIMP-3 Is Expressed During Fetal Development, Hair Growth Cycle, and Cancer Progression , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[23] D. Gomez,et al. Enhanced RNA expression of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) in human breast cancer , 1996, International journal of cancer.
[24] B. Vandenbunder,et al. Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. , 1996, The International journal of developmental biology.
[25] S. Chandler,et al. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. , 1996, Biochemical and biophysical research communications.
[26] Y. Okada,et al. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis , 1995, Molecular and cellular biology.
[27] M. Bissell,et al. Multi‐faceted regulation of cell differentiation by extracellular matrix , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] Y. DeClerck,et al. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. , 1994, Cancer research.
[29] A. Sonnenberg,et al. Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[30] R. Khokha,et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. , 1994, The Journal of biological chemistry.
[31] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[32] A. Riggs,et al. Genomic sequencing. , 1993, Methods in molecular biology.
[33] P. Leder,et al. Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes. , 1989, The American journal of pathology.
[34] W. Stetler-Stevenson,et al. Tissue inhibitor of metalloproteinase‐2 (TIMP‐2) has erythroid‐potentiating activity , 1992, FEBS letters.
[35] M. Bäckdahl,et al. Correlation between stromelysin‐3 mRNA level and outcome of human breast cancer , 1994, International journal of cancer.
[36] D. Rifkin,et al. Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.
[37] L. Liotta,et al. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. , 1989, The Journal of biological chemistry.
[38] B. Vandenbunder,et al. The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. , 1998, Journal of cell science.
[39] S. Haslam. Role of Sex Steroid Hormones in Normal Mammary Gland Function , 1987 .
[40] J. Woessner,et al. Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] W. Fauquette,et al. Characterization of morphogenetic and invasive abilities of human mammary epithelial cells: Correlation with variations of urokinase‐type plasminogen activator activity and type‐1 plasminogen activator inhibitor level , 1997, Biology of the cell.
[42] M. F. Smith,et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. , 1998, Reviews of reproduction.
[43] M. Flannery,et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. , 1996, Development.
[44] J. Fata,et al. Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice. , 1997, Blood.
[45] R. Dulbecco,et al. Marker evolution during the development of the rat mammary gland: stem cells identified by markers and the role of myoepithelial cells. , 1986, Cancer research.
[46] J. Williams,et al. Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. , 1983, Developmental biology.
[47] R. Langer,et al. Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. , 1980, Journal of pharmaceutical sciences.
[48] A. Eisen,et al. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. , 1991, The Journal of investigative dermatology.
[49] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[50] M. Day,et al. Cell Anchorage Regulates Apoptosis through the Retinoblastoma Tumor Suppressor/E2F Pathway* , 1997, The Journal of Biological Chemistry.
[51] Z. Werb,et al. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. , 1991, Development.
[52] S. Nandi,et al. Regulation of mammary epithelial cell growth in mice and rats. , 1990, Endocrine reviews.
[53] D. Gomez,et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.
[54] M. Neville,et al. The Mammary gland : development, regulation, and function , 1987 .
[55] R. Wieczorek,et al. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. , 1995, Endocrinology.
[56] Jack P. Witty,et al. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. , 1995, Molecular biology of the cell.
[57] Z. Werb,et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.
[58] Y. Konttinen,et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[59] C H Streuli,et al. Laminin mediates tissue-specific gene expression in mammary epithelia , 1995, The Journal of cell biology.
[60] J. H. Dierendonck,et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[61] Q. Sang,et al. Complex role of matrix metalloproteinases in angiogenesis , 1998, Cell Research.
[62] K. Suzuki,et al. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. , 1995, Endocrinology.
[63] D. Melton,et al. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.
[64] Z. Werb,et al. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Khokha,et al. Murine tissue inhibitor of metalloproteinases—4 (Timp—4): cDNA isolation and expression in adult mouse tissues 1 , 1997, FEBS letters.
[66] C. López-Otín,et al. The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction* , 1997, The Journal of Biological Chemistry.
[67] Y. Okada,et al. Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. , 1987, The Journal of rheumatology.
[68] L. Fink,et al. Removal of basement membrane in the involuting breast. , 1976, Laboratory investigation; a journal of technical methods and pathology.
[69] R. Langer,et al. Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.
[70] R. Khokha,et al. Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse. , 1996, Biology of reproduction.
[71] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[72] L. Matrisian,et al. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. , 1996, The American journal of pathology.
[73] T. Cawston. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. , 1998, Molecular medicine today.
[74] L. Liotta,et al. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. , 1990, The American journal of pathology.
[75] C. Daniel,et al. Postnatal Development of the Rodent Mammary Gland , 1987 .
[76] R. Khokha,et al. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[77] K. Brocklehurst,et al. Kinetic analysis of the mechanism of interaction of full-length TIMP-2 and gelatinase A: evidence for the existence of a low-affinity intermediate. , 1998, Biochemistry.
[78] K. Suzuki,et al. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. , 1994, The Journal of biological chemistry.
[79] John M. Whitelock,et al. The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases (*) , 1996, The Journal of Biological Chemistry.
[80] Y. Sasaguri,et al. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. , 1992, The Biochemical journal.
[81] A. Shinagawa,et al. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.
[82] A Yasui,et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. , 1990, European journal of biochemistry.
[83] G. Schultz,et al. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. , 1995, Development.
[84] M. Bissell,et al. Interaction of mouse mammary epithelial cells with collagen substrata: regulation of casein gene expression and secretion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.